Ghamlouch, H., Ouled-Haddou, H., Guyart, A., Regnier, A., Trudel, S., Claisse, J., . . . Gubler, B. (2014). TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells. Frontiers Media S.A.
Citación estilo ChicagoGhamlouch, Hussein, et al. TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate Into CD20(+) Antibody-Secreting Cells. Frontiers Media S.A, 2014.
Cita MLAGhamlouch, Hussein, et al. TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate Into CD20(+) Antibody-Secreting Cells. Frontiers Media S.A, 2014.
Precaución: Estas citas no son 100% exactas.